Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its updated t:slim X2 insulin pump software with Dexcom (Nasdaq:DXCM) CGMs in Canada.
San Diego-based Tandem now offers the t:slim X2 pump software with the Dexcom G6 and G7 continuous glucose monitors (CGMs). Health Canada authorized the combination, which already exists on the U.S. market, for sale in the country. The companies also offer the combination in other geographies after launching in early 2024. The integration gives users in Canada more of a choice in how they manage their diabetes.
Tandem expects to make the integrated offering available this fall in Canada. It plans to email instructions to Canadian users with an in-warranty t:slim X2 pump, offering an option between G7 and G6 with a free remote software update. New customers will receive pumps pre-loaded with the updated software.
Dexcom’s G7 CGM features a 60% size reduction from G6 and offers a 30-minute warmup period (down from waiting two hours for glucose readings to begin in the past). G7 provides more information in one place with personalized insights, extended-wear design and more. It features a simple wear experience, starting with unscrewing a cap. The user then puts the sensor on their body and pushes a button. The device is then turned on and can be paired with a smartphone.
Tandem’s t:slim X2 pump uses CGM data to predict glucose levels 30 minutes ahead and automatically adjust insulin if needed. It offers customizable personal profiles and optional settings for sleep or exercise activity. Tandem also offers a variety of on-body infusion sets for more convenience and flexibility.
In a news release, André Côté, EVP and GM of Dexcom Canada, said the launch “underscores the shared commitment between Dexcom and Tandem to provide cutting-edge technology that empowers individuals with diabetes to live better and feel better every day.”
“This integration marks the first time an AID system in Canada is compatible with both Dexcom G7 and Dexcom G6 CGMs, demonstrating our commitment to continued leadership in advancing AID systems and offering choice,” said Mark Novara, EVP and CCO of Tandem Diabetes Care. “We are proud to celebrate more than 10 years of partnership with Dexcom through this milestone that allows users in Canada to benefit from our No. 1 recommended insulin pump brand, now with Dexcom’s most advanced CGM technology.”